4.7 Review

Targeting Aggressive Pituitary Adenomas at the Molecular Level-A Review

期刊

JOURNAL OF CLINICAL MEDICINE
卷 11, 期 1, 页码 -

出版社

MDPI
DOI: 10.3390/jcm11010124

关键词

pituitary adenomas; adjuvant treatment; hormone secretion; invasiveness; molecular biology; proliferation

向作者/读者索取更多资源

Pituitary adenomas (PAs) are mostly benign tumors, but up to 10% exhibit aggressive behavior. This article provides an overview of target structures in aggressive PAs and summarizes current clinical trials for treating PAs. Drug targets in PAs are based on general features of tumor cells and include immune checkpoints and signal pathways involved in tumor cell proliferation, migration, and angiogenesis. Dopamine agonists (DAs) are the first line treatment for prolactinomas and have potential to treat other subtypes of PAs. Targeting the invasive behavior of PAs may improve therapy.
Pituitary adenomas (PAs) are mostly benign endocrine tumors that can be treated by resection or medication. However, up to 10% of PAs show an aggressive behavior with invasion of adjacent tissue, rapid proliferation, or recurrence. Here, we provide an overview of target structures in aggressive PAs and summarize current clinical trials including, but not limited to, PAs. Mainly, drug targets in PAs are based on general features of tumor cells such as immune checkpoints, so that programmed cell death 1 (ligand 1) (PD-1/PD-L1) targeting may bear potential to cure aggressive PAs. In addition, epidermal growth factor receptor (EGFR), mammalian target of rapamycin (mTOR), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and their downstream pathways are triggered in PAs, thereby modulating tumor cell proliferation, migration and/or tumor angiogenesis. Temozolomide (TMZ) can be an effective treatment of aggressive PAs. Combination of TMZ with 5-Fluorouracil (5-FU) or with radiotherapy could strengthen the therapeutic effects as compared to TMZ alone. Dopamine agonists (DAs) are the first line treatment for prolactinomas. Dopamine receptors are also expressed in other subtypes of PAs which renders DAs potentially suitable to treat other subtypes of PAs. Furthermore, targeting the invasive behavior of PAs could improve therapy. In this regard, human matrix metalloproteinase (MMP) family members and estrogens receptors (ERs) are highly expressed in aggressive PAs, and numerous studies demonstrated the role of these proteins to modulate invasiveness of PAs. This leaves a number of treatment options for aggressive PAs as reviewed here.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Medicine, Research & Experimental

MicroRNA-149 Regulates Proliferation, Migration, and Invasion of Pituitary Adenoma Cells by Targeting ADAM12 and MMP14

Zhuo Zhang, Agnes Schaefer, Benjamin Voellger, Jun-Wen Wang, Ting Lei, Christopher Nimsky, Jorg W. Bartsch

Summary: This study demonstrates that the downregulation of miRNA-149 is associated with the invasiveness of PA cells, and it exerts its effects by regulating the expression of ADAM12 and MMP-14.

CURRENT MEDICAL SCIENCE (2022)

Article Oncology

Basal cell adhesion molecule promotes metastasis-associated processes in ovarian cancer

Suresh Sivakumar, Sonja Lieber, Damiano Librizzi, Corinna Keber, Leah Sommerfeld, Florian Finkernagel, Katrin Roth, Silke Reinartz, Joerg W. Bartsch, Johannes Graumann, Sabine Mueller-Bruesselbach, Rolf Mueller

Summary: Different forms of BCAM protein are associated with metastasis and poor prognosis in ovarian cancer. The soluble form of BCAM inhibits tumor cell adhesion and migration, but promotes the dispersion and invasion of tumor cell spheroids. These findings provide new insights for the treatment of ovarian cancer.

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Article Clinical Neurology

Temporal encephaloceles and coexisting epileptogenic lesions

Panagiota-Eleni Tsalouchidou, Johann Philipp Zoellner, Annika Kirscht, Christina Julia Mueller, Christopher Nimsky, Maximilian Schulze, Elke Hattingen, Georgios Chatzis, Thomas M. Freiman, Adam Strzelczyk, Sven Fuest, Katja Menzler, Felix Rosenow, Susanne Knake

Summary: This study aimed to identify coexisting structural lesions in patients with epilepsy and known temporal encephaloceles (TEs). Results showed that TEs can occur with other lesions, potentially impacting surgical evaluation and approach. Additionally, TEs may be associated with malformations of cortical development.

EPILEPSIA OPEN (2023)

Article Oncology

Changes in calpain-2 expression during glioblastoma progression predisposes tumor cells to temozolomide resistance by minimizing DNA damage and p53-dependent apoptosis

Maren Nicole Stillger, Chia-Yi Chen, Zon Weng Lai, Mujia Li, Agnes Schaefer, Axel Pagenstecher, Christopher Nimsky, Joerg Walter Bartsch, Oliver Schilling

Summary: This study found that the expression of calcium-dependent protease calpain-2 is increased in glioblastoma. Treatment with a calpain inhibitor increased the sensitivity of primary glioblastoma cells to TMZ. The knockdown of calpain-2 resulted in DNA damage and disrupted TP53 signaling. Therefore, calpain-2 may serve as a prognostic factor for GBM outcome.

CANCER CELL INTERNATIONAL (2023)

Article Clinical Neurology

Non-motor effects of deep brain stimulation in Parkinson?s disease motor subtypes

Stefanie T. Jost, Agni Konitsioti, Philipp A. Loehrer, Keyoumars Ashkan, Alexandra Rizos, Anna Sauerbier, Maria Gabriela dos Santos Ghilardi, Franz Rosenkranz, Lena Strobel, Alexandra Gronostay, Michael T. Barbe, Julian Evans, Veerle Visser-Vandewalle, Christopher Nimsky, Gereon R. Fink, Monty Silverdale, Rubens G. Cury, Erich T. Fonoff, Angelo Antonini, K. Ray Chaudhuri, Lars Timmermann, Pablo Martinez-Martin, Haidar S. Dafsari

Summary: This study suggests that patients with 'postural instability and gait difficulty' (PIGD) may experience more beneficial non-motor effects compared to patients with 'tremor-dominant' symptoms undergoing deep brain stimulation (DBS) for Parkinson's disease (PD). These differences in clinical efficacy on non-motor aspects should be taken into consideration when advising and monitoring PD patients undergoing DBS.

PARKINSONISM & RELATED DISORDERS (2023)

Article Clinical Neurology

Focal Cortex Stimulation With a Novel Implantable Device and Antiseizure Outcomes in 2 Prospective Multicenter Single-Arm Trials

Andreas Schulze-Bonhage, Martin Hirsch, Susanne Knake, Elisabeth Kaufmann, Josua Kegele, Michael Rademacher, Kristl Vonck, Volker Arnd Coenen, Martin Glaser, Carolin Jenkner, Yaroslav Winter, Sergiu Groppa, EASEE Study Grp

Summary: A pooled analysis of two clinical trials showed that a novel stimulation device could effectively reduce seizure frequency in patients with drug-refractory focal epilepsy, providing a promising treatment option for patients with a predominant epileptic focus.

JAMA NEUROLOGY (2023)

Article Neurosciences

Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells

Lara Evers, Agnes Schaefer, Raffaella Pini, Kai Zhao, Susanne Stei, Christopher Nimsky, Joerg W. Bartsch

Summary: This study explored changes in miRNA expression profiles in patient-derived glioblastoma stem-like cells (GSCs) upon differentiation into glial fiber acid protein (GFAP)-expressing astrocytic tumor cells. The results showed that miR-17-5p and miR-425-5p were downregulated, while miR-223-3p and let-7-5p were upregulated in differentiated cells. Among them, miR-425-5p consistently showed the highest downregulation in all GSCs. Transfection of a 425-5p miRNA mimic demonstrated downregulation of GFAP protein in differentiated patient-derived GBM cells, suggesting direct regulation of miRNAs in the GSC/GBM cell transition.

BRAIN SCIENCES (2023)

Article Oncology

A disintegrin and metalloproteinase 22 activates integrin β1 through its disintegrin domain to promote the progression of pituitary adenoma

Biao Xing, Zhuowei Lei, Zihan Wang, Quanji Wang, Qian Jiang, Zhuo Zhang, Xiaojin Liu, Yiwei Qi, Sihan Li, Xiang Guo, Yanchao Liu, Xingbo Li, Kai Shu, Huaqiu Zhang, Joerg Walter Bartsch, Christopher Nimsky, Yimin Huang, Ting Lei

Summary: This study found that ADAM22 is overexpressed in pituitary adenoma (PA) and promotes its growth and invasion through activating the ITGB1 signaling pathway. It also revealed that PKA may regulate ADAM22 levels through phosphorylation and delaying degradation. ITGB1 may be a potential therapeutic target for PA.

NEURO-ONCOLOGY (2023)

Article Oncology

Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism

Miguel Cosenza-Contreras, Agnes Schafer, Justin Sing, Lena Cook, Maren N. Stillger, Chia-Yi Chen, Jose Villacorta Hidalgo, Niko Pinter, Larissa Meyer, Tilman Werner, Darleen Bug, Zeno Haberl, Oliver Kuebeck, Kai Zhao, Susanne Stei, Anca Violeta Gafencu, Radu Ionita, Felix M. Brehar, Jaime Ferrer-Lozano, Gloria Ribas, Leo Cerda-Alberich, Luis Marti-Bonmati, Christopher Nimsky, Alexis Van Straaten, Martin L. Biniossek, Melanie Foll, Nina Cabezas-Wallscheid, Jorg Buscher, Hannes Rost, Armelle Arnoux, Jorg W. Bartsch, Oliver Schilling

Summary: This study utilized proteomics and lipidomics to analyze patient-matched initial and recurrent glioblastoma specimens, revealing increased immune cell infiltration and extracellular matrix reorganization in recurrent glioblastoma. ASAH1 and SYNM were identified as potential plasma markers for the progression of recurrent glioblastoma.

NEURO-ONCOLOGY (2023)

Article Clinical Neurology

Case report: Unilateral GPi DBS in secondary myoclonus-dystonia syndrome after acute disseminated encephalomyelitis

Alexander Calvano, Laura Beccaria, Lars Timmermann, Miriam H. A. Bopp, Marko Gjorgjevski, Christopher Nimsky, David J. Pedrosa

Summary: Personalized structural considerations, particularly using patient-specific connectome analysis, can provide important insights for the treatment of secondary myoclonus-dystonia syndromes.

FRONTIERS IN NEUROLOGY (2023)

Article Medicine, General & Internal

Implementation and Assessment of a Laparotomy-Assisted Three-Port Fetoscopic Spina Bifida Repair Program

Corinna Keil, Siegmund Koehler, Benjamin Sass, Maximilian Schulze, Gerald Kalmus, Michael Belfort, Nicolas Schmitt, Daniele Diehl, Alice King, Stefanie Gross, Caitlin D. Sutton, Luc Joyeux, Mirjam Wege, Christopher Nimsky, Wiliam E. Whitehead, Eberhard Uhl, Thierry A. G. M. Huisman, Bernd A. Neubauer, Stefanie Weber, Helmut Hummler, Roland Axt-Fliedner, Ivonne Bedei

Summary: Open spina bifida (OSB) is a congenital malformation that can be treated through prenatal fetal therapy. The University of Giessen and Marburg (UKGM) has successfully performed a three-port, three-layer fetoscopic repair of OSB via laparotomy-assisted approach. The transfer of technique to a different setting is possible with experienced centers and intensive multidisciplinary preparation and training.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Biotechnology & Applied Microbiology

A Novel Registration Method for a Mixed Reality Navigation System Based on a Laser Crosshair Simulator: A Technical Note

Ziyu Qi, Miriam H. A. Bopp, Christopher Nimsky, Xiaolei Chen, Xinghua Xu, Qun Wang, Zhichao Gan, Shiyu Zhang, Jingyue Wang, Haitao Jin, Jiashu Zhang

Summary: This study proposes a novel registration method for mixed reality navigation (MRN) using a laser crosshair simulator, which achieves low user dependency, high accuracy, and clinical applicability. The method was successfully implemented and showed promising results in efficiency and intuitiveness. It marks a valuable advancement in low-cost, easy-to-use MRN systems and has the potential to improve surgical outcomes.

BIOENGINEERING-BASEL (2023)

Article Health Care Sciences & Services

Dynamics in the Neurotrauma Catchment Area of a German University Hospital during the COVID-19 Pandemic

Rosita Rupa, Tim Vladimirov, Mirza Pojskic, Christopher Nimsky, Benjamin Voellger

Summary: During the COVID-19 pandemic, our neurosurgical department maintained an open-door policy and admitted more neurotrauma patients from outside our district compared to previous years. There was a significant increase in the number of patients admitted in 2020 and 2021. During high COVID-19 caseload weeks, we observed an increased number of neurotrauma patients from densely populated areas in our catchment area, with no higher in-house mortality observed.

HEALTHCARE (2022)

暂无数据